Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1953 1
1956 1
1957 1
1965 1
1968 2
1970 1
1971 2
1972 13
1973 5
1974 5
1975 5
1976 6
1977 4
1978 2
1979 2
1980 3
1981 4
1982 4
1983 6
1984 5
1985 9
1986 6
1987 2
1988 4
1989 2
1990 3
1991 5
1992 5
1993 3
1994 6
1995 9
1996 6
1997 7
1998 6
1999 11
2000 7
2001 13
2002 7
2003 12
2004 8
2005 15
2006 18
2007 19
2008 14
2009 14
2010 21
2011 22
2012 18
2013 18
2014 21
2015 20
2016 20
2017 20
2018 24
2019 24
2020 13
2021 26
2022 18
2023 20
2024 16
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

545 results

Results by year

Filters applied: . Clear all
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
CCR1 antagonists.
Cheng JF, Jack R. Cheng JF, et al. Among authors: jack r. Mol Divers. 2008 Feb;12(1):17-23. doi: 10.1007/s11030-008-9076-x. Epub 2008 Jun 17. Mol Divers. 2008. PMID: 18560988 Review.
Reply to Authors.
Branch-Elliman W, Schechter-Perkins EM, Jack RS, van den Berg P, Epshtein I, Nelson R, Oster E. Branch-Elliman W, et al. Among authors: jack rs. Clin Infect Dis. 2021 Sep 15;73(6):e1405-e1407. doi: 10.1093/cid/ciab354. Clin Infect Dis. 2021. PMID: 33895805 No abstract available.
Commentary.
Jack R. Jack R. Clin Chem. 2018 Oct;64(10):1438. doi: 10.1373/clinchem.2018.288134. Clin Chem. 2018. PMID: 30266719 No abstract available.
Reply to Author.
Branch-Elliman W, Jack RS, Schechter-Perkins EM, van den Berg P, Epshtein I, Oster E, Nelson R. Branch-Elliman W, et al. Among authors: jack rs. Clin Infect Dis. 2022 Jan 29;74(2):370-371. doi: 10.1093/cid/ciab440. Clin Infect Dis. 2022. PMID: 33988221 No abstract available.
Evolution of Immunity and Pathogens.
Jack RS. Jack RS. Results Probl Cell Differ. 2015;57:1-20. doi: 10.1007/978-3-319-20819-0_1. Results Probl Cell Differ. 2015. PMID: 26537375 Review.
Evolution of immunity and pathogens.
Howard JC, Jack RS. Howard JC, et al. Among authors: jack rs. Eur J Immunol. 2007 Jul;37(7):1721-3. doi: 10.1002/eji.200790026. Eur J Immunol. 2007. PMID: 17587195 Free article. Review.
Bacteriocins of gram-positive bacteria.
Jack RW, Tagg JR, Ray B. Jack RW, et al. Microbiol Rev. 1995 Jun;59(2):171-200. doi: 10.1128/mr.59.2.171-200.1995. Microbiol Rev. 1995. PMID: 7603408 Free PMC article. Review.
545 results